Orthofix Medical Inc (OFIX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $277.17M
Last updated: Nov 17, 2026 at 4:10 PM ET
Orthofix Medical Inc (OFIX) Statistics
Orthofix Medical (OFIX) has a market cap of $277.17M and an enterprise value of $412.69M. Its share count is up 3.55% from a year earlier.
Total Valuation
Enterprise value is 48.90% above the market cap, as debt exceeds cash.
| Market Cap | $277.17M |
|---|---|
| Enterprise Value | $412.69M |
| Latest price (Nov 17, 2026) | $6.67 |
Key Dates
The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.6x. Its year-end P/S ranged from 0.7x to 2.3x from 2016 to 2025.
| P/S Ratio | 0.3x |
|---|---|
| Forward P/S | 0.3x |
| P/B Ratio | 0.6x |
| P/TBV Ratio | 1.6x |
| P/OCF Ratio | 65.6x |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.1x EBITDA.
| EV / Sales | 0.5x |
|---|---|
| EV / EBITDA | 11.1x |
Price Statistics
The stock is down 55.38% over 52 weeks and trades 25.64% below its 50-day average.
| Beta (1Y) | 1.03 |
|---|---|
| 52-Week Change | -55.38% |
| 1-Month Change | -30.45% |
| 3-Month Change | -36.35% |
| 6-Month Change | -44.83% |
| 5-Year Change | -74.79% |
| 10-Year Change | -75.25% |
| Total Return (1Y) | -55.38% |
| Total Return (3Y CAGR) | -14.01% |
| Total Return (5Y CAGR) | -26.00% |
| Return vs SPY (1Y) | -65.24% |
| Max Drawdown (1Y) | -58.83% |
| Max Drawdown (3Y) | -66.68% |
| Sharpe Ratio (1Y) | -1.47 |
| Correlation with SPY (1Y) | 0.27 |
| 50-Day Average | $8.97 |
| 200-Day Average | $10.75 |
| 52-Week Range | $6.52 to $16.42 |
| RSI (14 Days) | 29.7 |
| Average Volume (20 Days) | 694.55K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.11x current liabilities, and total debt is 0.52x shareholder equity.
| Current Ratio | 3.11x |
|---|---|
| Quick Ratio | 1.74x |
| Debt / Equity | 0.52x |
| Debt / EBITDA | 5.99x |
| Interest Coverage | -0.97x |
Returns and Efficiency
Return on invested capital is -3.27% over the last 12 months, against a 5-year average of -12.86%.
| Return on Equity (ROE) | -10.48% |
|---|---|
| Return on Assets (ROA) | -5.26% |
| Return on Invested Capital (ROIC) | -3.27% |
| Return on Capital Employed (ROCE) | -2.97% |
| ROE (5Y Average) | -17.61% |
| ROA (5Y Average) | -10.73% |
| ROIC (5Y Average) | -12.86% |
| Asset Turnover | 0.99x |
| Inventory Turnover | 1.30x |
| Receivables Turnover | 6.25x |
| Cash Conversion Cycle | 248 days |
Scores
OFIX has an Altman Z-Score of 1.02, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.02 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $835.41M over the last 12 months is up 2.12% from the 12 months before.
| Revenue | $835.41M |
|---|---|
| Revenue Growth (YoY) | +2.12% |
| Gross Profit | $592.14M |
| Operating Income | -$20.53M |
| Pretax Income | -$43.27M |
| Net Income | -$45.00M |
| EBITDA | $37.04M |
| EBIT | -$21.28M |
| Reported EPS (TTM) | -$0.41 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 50.20% of the $855.76M in total assets.
| Cash and Equivalents | $86.32M |
|---|---|
| Total Debt | $221.85M |
| Net Debt | $135.53M |
| Net Debt Per Share | $3.29 |
| Working Capital | $292.40M |
| Shareholder Equity | $429.57M |
| Book Value Per Share | $10.43 |
| Tangible Book Value | $171.73M |
| Tangible Book Per Share | $4.17 |
| Total Assets | $855.76M |
| Total Liabilities | $426.19M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $48.69M of capital spending, operating cash flow left -$44.46M of free cash flow.
| Operating Cash Flow | $4.23M |
|---|---|
| Capital Expenditures | $48.69M |
| Free Cash Flow | -$44.46M |
| FCF Per Share | -$1.10 |
| Depreciation and Amortization | $58.32M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.46%, against a 5-year average of -8.76%.
| Gross Margin | 70.88% |
|---|---|
| Operating Margin | -2.46% |
| Pretax Margin | -5.18% |
| Net Margin | -5.39% |
| EBITDA Margin | 4.43% |
| EBIT Margin | -2.55% |
| FCF Margin | -5.32% |
| Gross Margin (5Y Average) | 70.14% |
| Operating Margin (5Y Average) | -8.76% |
| Net Margin (5Y Average) | -11.96% |
Growth
Revenue grew 21.30% a year over 3 years, and EPS 21.48% a year.
| Revenue Growth (3Y CAGR) | +21.30% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.13% |
| EPS Growth (3Y CAGR) | +21.48% |
| EPS Growth (5Y CAGR) | +16.56% |
| Book Value Per Share Growth (2Y CAGR) | -16.35% |
| Tangible Book Per Share Growth (2Y CAGR) | -23.00% |
Dividends and Yields
OFIX does not pay a dividend. Its free cash flow yield is -16.19%.
| FCF Yield | -16.19% |
|---|---|
| Buyback Yield | -1.99% |
| Shareholder Yield | -1.99% |
Peer Position
Against 12 similar companies, OFIX has the lowest P/S.
P/S RatioPeer median 2.3x
ROICPeer median -17.35%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.35%
| P/S Ratio | 0.3x vs 2.3x median |
|---|---|
| ROIC | -3.27% vs -17.35% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +2.12% vs +11.35% median |
Analyst Forecast
Consensus estimates put revenue growth at -0.14% and EPS growth at -42.15% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -0.14% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -42.15% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OFIX
What is OFIX's market cap?
Orthofix Medical has a market cap of $277.17M. Its enterprise value, which adds debt and subtracts cash, is $412.69M.
How many shares of OFIX are outstanding?
Orthofix Medical has 41.18M shares outstanding. The count is up 3.55% from a year earlier.
Does OFIX pay a dividend?
No. Orthofix Medical does not pay a dividend.
How much debt does OFIX have?
Orthofix Medical has $221.85M of total debt and $86.32M of cash and equivalents, a net debt position of $135.53M.
OFIX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors